# Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)

> **NCT01939886** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 219 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Mefloquine - Artesunate
- **DRUG:** Artemether-lumefantrine combination

## Key facts

- **NCT ID:** NCT01939886
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2013-11-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939886, "Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01939886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*